REKYNRA
Live / Registered — Registered (as of 07 Feb 2023)
What this means for you
Registered since 07 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88492508
- Registration number
- 6974832
- Mark type
- Stylized text
- Filed
- 27 Jun 2019
- Published for opposition
- 29 Oct 2019
- Registered
- 07 Feb 2023
- Attorney of record
- Ann K. Ford
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of stroke; pharmaceuticals for the treatment of neurological disease, pharmaceuticals for the treatment of ischemia, pharmaceuticals for the treatment of neuronal injury, and pharmaceuticals for the treatment of neurodegenerative diseases; pharmaceuticals and pharmaceutical preparations for the treatment of subarachnoid hemorrhage, strokes associated with vascular interventions, traumatic brain injury, surgical brain injuries, radiation-induced brain injuries, concussions, pain, anxiety, epilepsy, neuronal damage associated with epilepsy, Alzheimer's, tinnitus, retinal ischemia, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis
Owner
Prosecution history
- 07 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 04 Jan 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Jan 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Dec 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Dec 2022 — USE AMENDMENT FILED
- 16 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 17 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2022 — SOU EXTENSION 5 GRANTED
- 09 Jun 2022 — SOU EXTENSION 5 FILED
- 16 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Nov 2021 — SOU EXTENSION 4 GRANTED
- 24 Nov 2021 — SOU EXTENSION 4 FILED